CXCL8 and cancer: Preclinical and clinical studies have found cancer-associated fibroblast-derived IL-8 to increase PDAC invasiveness, while Fusobacterium nucleatum in the tumor microenvironment promotes IL-8 secretion and autocrine signaling in PDAC cells to boost invasion [49–51].